The survival rates for multiple myeloma are 62, 44 and 29 months for stages one, two and three, respectively, according to Cancer.org. Physicians use survival rates for multiple myeloma, a type of cancer that affects plasma cells, to gauge a patient’s outlook or prognosis.
Survival rates are based on previous outcomes for individuals in a particular group of patients who suffered from the disease. However, survival rates do not accurately predict what may happen in specific patients' cases. Survival rates are estimated from the time that treatment for multiple myeloma first commenced.
According to WebMD, the multiple myeloma risk is higher in male, African-American and obese individuals aged 65 years and over.
